Related Experiment Video

Updated: Sep 27, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.6K

Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy

Marie-Eve Wedge1,2, Victoria A Jennings1,3,4, Mathieu J F Crupi1,5

  • 1Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.

Nature Communications
|April 8, 2022
PubMed

Insights

Oncolytic viruses (OVs) engineered with artificial microRNAs (amiRNAs) show promise for cancer therapy. A novel amiRNA enhances OV replication and targets ARID1A, leading to synthetic lethality in tumor cells.

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Background:

  • Cancer therapeutics require innovative multiplex strategies to combat tumors effectively.
  • Oncolytic viruses (OVs) are emerging as multi-mechanistic immunotherapeutic agents for cancer treatment.

Purpose of the Study:

  • To identify virus-encoded artificial microRNAs (amiRNAs) that enhance oncolytic virus replication.
  • To investigate the mechanisms of OV resistance and develop combination therapies.

Main Methods:

  • In vitro screening of virus-encoded amiRNAs to identify those conferring a replicative advantage to the VSVΔ51 OV platform.
  • Target validation of identified amiRNAs, including ARID1A, and assessment of combination therapy with small-molecule inhibitors (EZH2).
  • Evaluation of intercellular transfer of amiR-4 via extracellular vesicles for bystander killing effects.

Main Results:

  • A unique amiRNA, amiR-4, was identified that enhances VSVΔ51 OV replication.
  • ARID1A was validated as a key protein involved in resistance to OV replication.
  • Combined targeting of ARID1A and EZH2 resulted in synthetic lethal killing of both infected and uninfected tumor cells.
  • Extracellular vesicles mediated the intercellular transfer of amiR-4, leading to bystander killing.

Conclusions:

  • Oncolytic viruses can serve as effective delivery vehicles for amiRNA therapeutics.
  • Combination therapy involving OVs, amiRNAs, small molecules, and potentially immune checkpoint inhibitors offers a promising strategy for cancer treatment.
  • The study highlights the potential of virus-directed amiRNA delivery for overcoming OV resistance and enhancing anti-tumor efficacy.

More Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

9.2K
In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.7K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
691
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.3K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
535
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.5K